Characterization of an immunosuppressive anti-CD40 ligand monoclonal antibody

Hybridoma

Volumn 17, Issue 5, 1998, Pages 463-470

  Kim, Kwang Mi ^a   Min, Hye Young ^a   Jung, Seung Hye ^a   Lee, Tae Ho ^b   Kim, Joong Gon ^a   Kang, Chang Yuil ^a  

^a Seoul National University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CHIMERIC ANTIBODY; FC RECEPTOR; FREUND ADJUVANT; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IONOMYCIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2B2; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL TRANSPLANTATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

ANIMALIA; BOVINAE; MURINAE;

EID: 0031696782     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.463     Document Type: Article

References (26)

1. Vercelli D, Jabara HH, Arai KI, and Geha RS: Induction of human IgE synthesis requires interleukin 4 and T/B cell interaction involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med 1989;169:1295-1307.
2. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, et al.: Molecular and biologic characterization of a murine ligand for CD40. Nature 1992;357:80-82.
3. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, and Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci USA 1992;89:6550-6554.
4. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Anderson S, Noelle RJ, Stamenkovic I, Ledbetter JA, and Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992;11:4313-4321.
5. Graf D, Korthauer U, Mages HW, Senger G, and Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 1992;22:3191-3194.
6. Fanslow W, Anderson D, Grabstein KH, Clark EA, Cosman D, and Armitage R: Soluble forms of CD40 inhibit biologic responses of human B cells. J Immunol 1992;149:655-660.
7. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, et al.: Induction of human IgG synthesis in B cells by mast cells and basophiles. Nature 1993;365:340-343.
8. Volker H, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Miller-Berghaus G, and Kroczec RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-594.
9. Stamenkovic I, Clark EA, and Seed B: A B-lymphocyte activation molecules related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 1989;8:1403-1410.
10. Galy AHM, and Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992;149:775-782.
11. Jabara HH, Fu SM, Geha RS, and Vercelli D: CD40 and IgE: Synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990;172:1861-1864.
12. Lane P, Brocker T, Hubele S, Radovan E, Lanzavecchia A, and McConnell F: Soluble CD40 ligand signal to B cells in T cell-dependent activation. J Exp Med 1993;177:1209-1213.
13. Foy TM, Shepherd DM, Duried FH, Aruffo A, Ledbetter JA, and Nopelle RJ: In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 1993;178:1567-1575.
14. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche J, Simoneaux DK, Fanslow WC, Belmont J, and Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-993.
15. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, and Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993;72:291-300.
16. Disanto JP, Bonnefoy JY, Gauchat JF, Fischer A, and de Saint Basile G: CD40 ligand mutations X-linked immunodeficiency with hyper-IgM. Nature 1993;361:541-543.
17. Galfre G, Howe SC, Milstein C, Butcher GW, and Howard JC: Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature 1977;266:550-552.
18. Chirgwin JJ, Przbyla AE, MacDonald RJ, and Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
19. Kabat EA, Wu TT, Perrry HM, Gottesman KS, and Foeller C: Sequences of Proteins of Immunological Interest, 5th ed. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, Maryland, 1991.
20. Newman R, Alberts J, Anderson D, Carner K, Heard C, Norton F, Raab R, Reff M, Shuey S, and Hanna N: "Primatization" of recombinant antibodies for immunotherapy of human diseases: A macaque/human chimeric antibody against human CD4. Biotechnology 1992;10:1455-1460.
21. Kang CY, Hariharan K, Nara PL, Sodroski J, and Moore JP: Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. J Virol 1994;68:5854-5862.
22. Noelle RJ, Ledbetter JA, and Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol Today 1992;13:431-436.
23. Hsu YM, Lucci J, Su L, Ehrenfels B, Garber E, and Thomas D: Heteromultimeric complexes of CD40 ligands are present on the cell surface of human T lymphocytes. J Biol Chem 1997;272: 911-915.
24. Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ, Glickman-Nir E, Sippel KC, Rogers J, Cleary AM, Parker M, et al.: T lymphocyte T cell-B cell-activating molecule/CD40L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80(B7/BB-1) and enhance their costimulatory activity. J Immunol 1994;153:666-674.
25. Mosier DE, Gulizia RJ, Baird SM, and Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-259.
26. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J Exp Med 1995;182: 1875-1864.